Our Solutions

A New Era of Hemostasis

Breakthrough Amino Acid–Metal Complex Powered by MACS™

In trauma care and battlefield medicine, rapid hemostasis often determines life or death. Yet existing solutions suffer from limitations: poor absorbability, storage issues, lack of antimicrobial action, and high costs.

Inspired by the need for robust, ready-to-use field solutions, we repurposed our MACS™ platform—originally developed for anticancer and antibiotic applications—to create an advanced hemostatic material optimized for real-world emergencies.

MACS Hemostatic Powder Illustration

RealSeal Powered by MACS™

A Next-Generation Hemostatic Breakthrough

Rapid

Rapid

Safe

Safe

Scalable

Scalable

Speed & Efficiency

  • 81% faster than natural clotting
  • 30-40% more effective than current products

Biocompatibility

  • Amino acid-metal complex design
  • Nutrient-safe and cell-absorbable

Scalable Production

  • Clean, water-based, pharma-grade manufacturing

RealSeal transforms trauma care with speed, safety, and scale.

RealSeal Product Package

Core Innovations

  • MACS Click Synthesis

    The MACS technology represents a guarantee of high purity, high quality, and zero contamination.

  • Clean & Scalable Process

    The only clean, scalable platform for high-purity medical-grade amino acid-metal chelates.

  • Superior Performance

    30–40% faster clotting, 60–70% less blood loss vs competing products

  • Modular & Expandable Platform

    Over eight amino acid–metal complexes have already been successfully synthesized, forming a versatile platform suitable for diverse trauma applications including burn injuries, ulcerative wounds, and post-operative care.

Competitive Edge: MACS Hemostat vs. Existing Solutions

MACS Hemostat Chitosan / Zeolite
Technology Mechanism Metal Amino Click Synthesis (MACS) technology Physical expansion (chitosan or kaolin-based)
Hemostasis Efficiency Stops bleeding within 60 seconds (animal trials) 2–3 minutes to stop bleeding
Antibacterial Function Yes – integrated metal-based antimicrobial action No antibacterial function
Storage & Portability Powder form, long shelf life at room temperature Limited – some require special packaging or temperature
Ease of Use Directly pour into wound, no pre-treatment needed Requires preparation or application pressure
Biocompatibility High – amino acid-based, naturally absorbable Moderate – some users may have sensitivity
Scalability of Production High – clean water-based synthesis, low-cost process Medium – multi-step or animal-derived raw materials
Customization Potential Yes – modular design supports varied clinical formulations Low – fixed material mechanism
Cost Efficiency Lower production cost, scalable formulation Higher cost due to material constraints
Regulatory Path Potential Designed for easy clinical adoption and regulatory approval Existing products approved but with limitations
Technology Mechanism
MACS Hemostat
Metal–Amino Acid Coordination (MACS) synthesis at room temperature
Chitosan / Zeolite
Physical expansion (chitosan or kaolin-based)
Hemostasis Efficiency
MACS Hemostat
Stops bleeding within 60 seconds (animal trials)
Chitosan / Zeolite
2–3 minutes to stop bleeding
Antibacterial Function
MACS Hemostat
Yes – integrated metal-based antimicrobial action
Chitosan / Zeolite
No antibacterial function
Storage & Portability
MACS Hemostat
Powder form, long shelf life at room temperature
Chitosan / Zeolite
Limited – some require special packaging or temperature
Ease of Use
MACS Hemostat
Directly pour into wound, no pre-treatment needed
Chitosan / Zeolite
Requires preparation or application pressure
Biocompatibility
MACS Hemostat
High – amino acid-based, naturally absorbable
Chitosan / Zeolite
Moderate – some users may have sensitivity
Scalability of Production
MACS Hemostat
High – clean water-based synthesis, low-cost process
Chitosan / Zeolite
Medium – multi-step or animal-derived raw materials
Customization Potential
MACS Hemostat
Yes – modular design supports varied clinical formulations
Chitosan / Zeolite
Low – fixed material mechanism
Cost Efficiency
MACS Hemostat
Lower production cost, scalable formulation
Chitosan / Zeolite
Higher cost due to material constraints
Regulatory Path Potential
MACS Hemostat
Designed for easy clinical adoption and regulatory approval
Chitosan / Zeolite
Existing products approved but with limitations

RealSeal's Clinical Edge

Rapid Hemostasis

Rapid Hemostasis

Clots up to 81% faster

Clot Stability

Clot Stability

Forms stronger, more stable clots

Biocompatibility"

Biocompatibility

Nutrient-safe and cell-absorbable

Antibacterial Action

Antibacterial Action

Integrated metal-based protection

Degradability

Degradability

Naturally breaks down after use

Cost-Effectiveness

Cost-Effectiveness

Lower production cost, scalable supply

Application Scenarios

Emergency Medicine
Emergency Medicine
Battlefield & Military Use
Battlefield & Military Use
Disaster Response
Disaster Response
Surgery & Wound Management
Surgery & Wound Management
Medical Kits & Remote Care
Medical Kits & Remote Care

Technology Pipeline & Future Development

Technology Illustration

With 8+ amino acid–metal complexes already synthesized and validated, the MACS platform serves as a versatile modular system for developing next-generation hemostatic and wound care materials.

Future applications include:
  • Antibacterial wound gels
  • Burn and ulcer-specific dressings
  • Post-operative wound coatings

By leveraging its scalable, clean synthesis process, MACS technology enables rapid formulation, customization, and commercial readiness for diverse clinical use cases.

The MACS platform is ready for broader clinical validation and commercialization.

Let's co-develop the future of trauma care.

We welcome collaboration in clinical trials, licensing, or joint development.